Hims & Hers Health (82W) Stock Overview
Operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
82W Community Fair Values
Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.
Hims & Hers Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$39.15 |
| 52 Week High | US$69.68 |
| 52 Week Low | US$12.05 |
| Beta | 2.09 |
| 1 Month Change | -22.17% |
| 3 Month Change | -17.00% |
| 1 Year Change | 202.08% |
| 3 Year Change | 535.55% |
| 5 Year Change | n/a |
| Change since IPO | 216.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| 82W | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 3.3% | -0.8% | 1.1% |
| 1Y | 202.1% | 32.2% | 17.4% |
Return vs Industry: 82W exceeded the German Healthcare industry which returned 33.2% over the past year.
Return vs Market: 82W exceeded the German Market which returned 17.7% over the past year.
Price Volatility
| 82W volatility | |
|---|---|
| 82W Average Weekly Movement | 15.5% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in DE Market | 12.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 82W's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 82W's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,637 | Andrew Dudum | www.hims.com |
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care.
Hims & Hers Health, Inc. Fundamentals Summary
| 82W fundamental statistics | |
|---|---|
| Market cap | €8.81b |
| Earnings (TTM) | €166.46m |
| Revenue (TTM) | €1.73b |
Is 82W overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 82W income statement (TTM) | |
|---|---|
| Revenue | US$2.01b |
| Cost of Revenue | US$479.23m |
| Gross Profit | US$1.53b |
| Other Expenses | US$1.34b |
| Earnings | US$193.60m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.86 |
| Gross Margin | 76.20% |
| Net Profit Margin | 9.62% |
| Debt/Equity Ratio | 172.3% |
How did 82W perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/27 16:00 |
| End of Day Share Price | 2025/08/27 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hims & Hers Health, Inc. is covered by 20 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Allen Lutz | BofA Global Research |
| Allen Lutz | BofA Global Research |